GAITHERSBURG, Md., Nov. 22, 2021 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that members of the Company’s management team will be presenting virtually at the following conferences:

• Piper Sandler 33^rd Annual Virtual Healthcare Conference
  November 29-December 2, 2021
  Webcast available now

• 5^th Annual NASH Summit 2021
  November 30, 2021
  9:00 am Eastern Time

• 4^th Annual Evercore ISI HealthCONx Conference
  December 2, 2021
  10:55 am Eastern Time

Presentation materials, including webcast links to the Piper Sandler and Evercore ISI presentations, will be accessible on the Events section of the Altimmune website.

About Altimmune

Altimmune is a clinical stage biopharmaceutical company focused on developing treatments for obesity and liver diseases. Our pipeline includes next generation peptide therapeutics for obesity, NASH (pemvidutide), and chronic hepatitis B (HepTcell™). For more information, please visit www.altimmune.com.

Follow @Altimmune, Inc. on LinkedIn
Follow @AltimmuneInc on Twitter

Altimmune Investor & Media Contact:

Will Brown
Chief Financial Officer
Phone: 240-654-1450
wbrown@altimmune.com

Source: Altimmune, Inc